Newsfiscal.ai
Immutep Reports Quarterly Activities for Q1 FY27
· Published
Article summary
Immutep Limited released its quarterly activities report for the period ending September 30, 2026, highlighting clinical trial progress and a cash position of A$48.50 million.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…